Skip to content

Clinical trials

Phase 3 Pulmonary Disease, Chronic Obstructive trials in South Africa

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 3 Country / region: South Africa Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20033
20042
20051
20065
20071
20082
20097
20104
20118
20121
20136
20146
20152
20161
20201
20212
20221
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed54
Active, not recruiting2
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca14
GlaxoSmithKline14
Boehringer Ingelheim13
Novartis Pharmaceuticals7
Sanofi4
Hoffmann-La Roche2
Pearl Therapeutics, Inc.2
Bayer1
Chiesi Farmaceutici S.p.A.1
Mundipharma Research Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive60
Bronchitis, Chronic2
Lung Diseases2
Bronchial Diseases1
Bronchiolitis Obliterans Syndrome1
Bronchitis1
Cardiovascular Diseases1
Emphysema1
Lung Diseases, Obstructive1
Respiratory Tract Diseases1

Trials

Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.